No Data
Scilex Holding And Endeavor Distribution Partner For Sale And Distribution
Scilex Holding And Endeavor Distribution Partner For Sale And Distribution
Express News | Scilex Holding Co - to Explore Ways to Maximize the Value of Semnur and SP-102 Including by Way of Conducting a Spin-off, Merger, Dividend
Express News | Scilex Holding Co - Approved a Resolution to Authorize Management to Explore Ways in Which to Maximize Value of Semnur Pharmaceuticals and SP-102
HC Wainwright & Co. Reiterates Buy on Scilex Holding, Maintains $7 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Scilex Holding (NASDAQ:SCLX) with a Buy and maintains $7 price target.
Scilex Holding Announces Publication Of Trial Results For SP-102 (SEMDEXA) In PAIN Journal; Focuses On Non-Opioid Pain Management Products For Acute And Chronic Pain
The Phase 3 study results are being published in PAIN Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the International Association for the
Express News | Scilex Holding Company Announces Publication in Pain Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (Semdexa™) in Lumbosacral Radicular Pain (Sciatica)